World's Best Scientists 2026 revealed!
Award Badge
Medicine
Hungary
2026

D-Index & Metrics

Medicine

D-Index
98
Citations
97696
World Ranking
8715
National Ranking
3

Research.com Recognitions

  • 2026 - Research.com Medicine in Hungary Leader Award
  • 2025 - Research.com Medicine in Hungary Leader Award
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Béla Merkely is affiliated with Semmelweis University in Hungary and has a primary research focus in the field of Medicine, with 1966 publications listed under this category. Their work spans several subfields including Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, Pulmonary and Respiratory Medicine, and Biomedical Engineering.

The scientist's research covers a range of topics related to cardiovascular health, with the main focus areas as follows:

  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Effects of Exercise
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Valve Diseases and Treatments

Béla Merkely has an extensive publication record in several well-known academic venues. The most frequent publication venues include:

  • European Heart Journal
  • European Heart Journal - Cardiovascular Imaging
  • Journal of the American College of Cardiology
  • EP Europace
  • Cardiologia Hungarica

Among the recent papers authored by or involving Béla Merkely are:

  • "2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)", 2020, European Heart Journal
  • "2021 ESC Guidelines on cardiovascular disease prevention in clinical practice", 2021, European Heart Journal
  • "2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation", 2020, European Heart Journal
  • "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure", 2020, New England Journal of Medicine
  • "Empagliflozin in Heart Failure with a Preserved Ejection Fraction", 2021, New England Journal of Medicine

The scientist has collaborated frequently with several coauthors, indicating ongoing research partnerships. Frequent coauthors include:

  • Attila Kovács
  • Hajnalka Vágó
  • Pál Maurovich-Horvat
  • Tamás Radovits
  • Bálint Károly Lakatos

Béla Merkely's contributions have also been recognized with professional acknowledgments such as membership in the European Academy of Sciences and Arts.

Best Publications

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Jean-Philippe Collet;Holger Thiele;Emanuele Barbato;Olivier Barthélémy

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

    A Halliday;C Baigent;F Mach;B Mihaylova;B Mihaylova

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment eleva...

    C. W. Hamm;J.-P. Bassand;S. Agewall;J. Bax

  • Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

    M. Packer;S. D. Anker;J. Butler;G. Filippatos

  • Empagliflozin in heart failure with a preserved ejection fraction

    Stefan D Anker;Javed Butler;Gerasimos Filippatos;João P Ferreira

  • Catheter Ablation for Atrial Fibrillation with Heart Failure

    Nassir F. Marrouche;Johannes Brachmann;Dietrich Andresen;Jürgen Siebels

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyDeveloped by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)

    Michael Glikson;Jens Cosedis Nielsen;Mads Brix Kronborg;Yoav Michowitz

  • Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

    Christopher P. Cannon;Deepak L. Bhatt;Jonas Oldgren;Gregory Y.H. Lip

  • Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease

    Gregg W. Stone;Joseph F. Sabik;Patrick W. Serruys;Charles A. Simonton

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries

    Petr Widimsky;William Wijns;Jean Fajadet;Mark de Belder

  • 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

    Kenneth Dickstein;Panos E. Vardas;Angelo Auricchio;Jean-Claude Daubert

  • Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction

    Christian Spaulding;Patrick Henry;Emmanuel Teiger;Kevin Beatt

  • Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm

  • Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.

    Aldo P Maggioni;Stefan D Anker;Ulf Dahlström;Gerasimos Filippatos

Frequent Co-Authors

Kurt Huber
Kurt Huber Sigmund Freud University Vienna
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Scott McNitt
Scott McNitt University of Rochester Medical Center
Arthur J. Moss
Arthur J. Moss University of Rochester Medical Center
Wojciech Zareba
Wojciech Zareba University of Rochester Medical Center
John J.V. McMurray
John J.V. McMurray University of Glasgow
Stephan Windecker
Stephan Windecker University of Bern
Ilan Goldenberg
Ilan Goldenberg University of Rochester Medical Center
Patrick W. Serruys
Patrick W. Serruys University of Galway
Piotr Ponikowski
Piotr Ponikowski Wrocław Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open up various career pathways in the healthcare sector. For those interested in leadership roles, health administration degrees online offer the flexibility to study while balancing other commitments. These programs focus on essential management and organizational skills that are highly valued in hospitals and other healthcare facilities.

Cost is often a major consideration. The cost of mha degree (Master of Healthcare Administration) differs widely by institution, so it is important to research affordable options that do not compromise on quality. For nurses looking to advance their clinical expertise, pursuing the cheapest dnp program (Doctor of Nursing Practice) may provide a practical, budget-conscious route to leadership and advanced practice roles.

Aspiring pharmacists can also benefit from flexible online learning with the online pharmd programs, allowing them to work toward a doctoral degree remotely. With careful planning and research, online programs make it possible to achieve advanced qualifications and diversify your opportunities within the healthcare industry.

Best Scientists Citing Béla Merkely

Trending Scientists

Recently Published Articles